Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Condition: Major Depressive Disorder (MDD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00330616
What this trial is testing

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Who this might be right for
Major Depressive Disorder (MDD)
GlaxoSmithKline 35
Post-approval studies (Phase 4)Study completedNCT01121484
What this trial is testing

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Who this might be right for
Major Depressive Disorder
Pfizer 439
Not applicableStudy completedNCT03026036
What this trial is testing

Neuroimaging Studies of Reward Processing in Depression

Who this might be right for
Major Depressive Disorder
Mclean Hospital 123
Testing effectiveness (Phase 2)Study completedNCT00962598
What this trial is testing

The Role Of Omega-3 Fatty Acids In Adolescent Depression

Who this might be right for
Depressive Disorder, Major
Icahn School of Medicine at Mount Sinai 16
Not applicableNot Yet RecruitingNCT07444463
What this trial is testing

Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder (MDD)
Central South University 400
Post-approval studies (Phase 4)UnknownNCT03881449
What this trial is testing

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

Who this might be right for
SchizophreniaMajor Depressive DisorderBi-Polar Disorder+1 more
Durham VA Medical Center 46
Not applicableEnded earlyNCT01226238
What this trial is testing

Online Self-help for Depressed Patients Awaiting Psychotherapy

Who this might be right for
Major Depressive Disorder
University of Luebeck 230
Not applicableStudy completedNCT02830399
What this trial is testing

Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Centre Hospitalier du Rouvray 56
Post-approval studies (Phase 4)UnknownNCT01391221
What this trial is testing

Inflammatory Markers and Cognitive Function in Major Depression

Who this might be right for
Major Depression
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal 20
Testing effectiveness (Phase 2)WithdrawnNCT05594667
What this trial is testing

Effect of SSRIs on Response to Psilocybin Therapy

Who this might be right for
DepressionMajor Depressive DisorderMild Depression+2 more
Cybin Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT02149836
What this trial is testing

Study to Treat Major Depressive Disorder (MDD) With a New Medication

Who this might be right for
Major Depressive DisorderDepression
Icahn School of Medicine at Mount Sinai 18
Not applicableStudy completedNCT00825799
What this trial is testing

Serum Markers as a Bioassay for Unipolar Depression

Who this might be right for
Major Depression
Steward St. Elizabeth's Medical Center of Boston, Inc. 160
Post-approval studies (Phase 4)UnknownNCT00628914
What this trial is testing

Brain Mechanisms and Targeting Insomnia in Major Depression

Who this might be right for
Major Depressive DisorderInsomnia
University of California, Los Angeles 60
Testing effectiveness (Phase 2)Study completedNCT01880593
What this trial is testing

Ketamine Plus Lithium in Treatment-Resistant Depression

Who this might be right for
Depression
Icahn School of Medicine at Mount Sinai 34
Testing effectiveness (Phase 2)WithdrawnNCT05438758
What this trial is testing

Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study

Who this might be right for
Treatment Resistant Major Depressive Disorder
Zylorion Health
Post-approval studies (Phase 4)Study completedNCT01185977
What this trial is testing

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

Who this might be right for
Major Depressive Disorder
University of California, Los Angeles 26
Large-scale testing (Phase 3)Study completedNCT02943577
What this trial is testing

Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 429
Testing effectiveness (Phase 2)Study completedNCT00125554
What this trial is testing

Metyrapone as Additive Treatment in Major Depression

Who this might be right for
Major Depressive Disorder
Universitätsklinikum Hamburg-Eppendorf 63
Not applicableStudy completedNCT05841030
What this trial is testing

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 545
Not applicableStudy completedNCT01691092
What this trial is testing

PET Imaging of mGLuR5 With Drug Challenge

Who this might be right for
Major Depressive DisorderPost-Traumatic Stress Disorder (PTSD)
Yale University 79
Next Page